Cellular senescence mediates fibrotic pulmonary disease
Open accessThe DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index; 18 of the 31 sources its claims cite were checked for support.
Abstract
Idiopathic pulmonary fibrosis (IPF) is a fatal disease characterized by interstitial remodelling, leading to compromised lung function. Cellular senescence markers are detectable within IPF lung tissue and senescent cell deletion rejuvenates pulmonary health in aged mice. Whether and how senescent cells regulate IPF or if their removal may be an efficacious intervention strategy is unknown. Here we demonstrate elevated abundance of senescence biomarkers in IPF lung, with p16 expression increasing with disease severity. We show that the secretome of senescent fibroblasts, which are selectively killed by a senolytic cocktail, dasatinib plus quercetin (DQ), is fibrogenic. Leveraging the bleomycin-injury IPF model, we demonstrate that early-intervention suicide-gene-mediated senescent cell ablation improves pulmonary function and physical health, although lung fibrosis is visibly unaltered. DQ treatment replicates benefits of transgenic clearance. Thus, our findings establish that fibrotic lung disease is mediated, in part, by senescent cells, which can be targeted to improve health and function.
Overview
CoChat Summary
## TL;DR
This study links cellular senescence to idiopathic pulmonary fibrosis (IPF) by showing that senescence markers rise with disease severity in human lung tissue and that senescent fibroblast secretions are profibrotic. In a bleomycin mouse model, clearing senescent cells improved lung function and physical health, and dasatinib plus quercetin (DQ) reproduced the benefits of transgenic senescent-cell ablation.
## Key findings
- In human IPF lung samples, CDKN2A (p16) was significantly upregulated and increased with disease severity; higher pulmonary p16 expression correlated with reduced FVC, diffusion capacity, and SF-12 physical component score.
- In IPF tissue, p16-positive epithelial cells and fibroblasts were found in fibroblastic foci and honeycomb lung, and TAF-positive cells / γH2A.X foci were significantly increased relative to controls.
- In the bleomycin mouse model, lung injury increased whole-lung p16 expression by threefold, and SASP-related transcripts including Mcp1, Il6, Mmp12, Col1a1, and Tgfβ rose after bleomycin exposure.
- Senescent fibroblast conditioned medium was fibrogenic in vitro: it increased αSMA positivity to 62% vs 21% with control conditioned medium, increased traction forces, and induced fibrosis genes such as ACTA2, COL1A1, COL1A2, and FN1.
- In mice, senescent-cell clearance improved pulmonary/physical outcomes: Penh rose about twofold after bleomycin and was diminished by AP or DQ; lung compliance fell by 40% in vehicle-treated bleomycin mice but only 15% with AP or DQ; body weight loss averaged 3.6 g with vehicle vs about 1.6 g with AP/DQ; treadmill distance to exhaustion was >37% further with AP/DQ than vehicle.
- The paper states that histological fibrosis reductions did not reach statistical significance, despite functional benefits.
## Methods
- Human data came from LTRC control and IPF lung tissue samples, including microarray and RNA-seq datasets; the paper reports IPF n=27 and control n=10 for p16 immunohistochemistry, and transcriptome analyses stratified by FVC severity.
- The mouse study used male Ink-Attac mice given aerosolized intratracheal bleomycin (2 U/kg) or PBS, then randomized to AP20187, dasatinib plus quercetin (DQ), or vehicle at either an early prevention timepoint or a later treatment timepoint.
- Analyses included FACS of lung fibroblasts, epithelial cells, and endothelial cells, immunohistochemistry / immunofluorescence, conditioned-medium assays in IMR90 fibroblasts, traction force microscopy, RT-PCR, and statistical modeling with regression and multiple-comparison correction.
## Limitations
- The paper states that the bleomycin model spontaneously resolves, with resolution varying by factors such as genetic background and microbiome, which limits interpretation of late-stage effects.
- The authors state that they could not disentangle senescence-dependent from senescence-independent events governing fibrosis resolution.
- Lung fibrosis histology did not improve significantly after senescent-cell clearance, despite functional gains; the paper itself notes this may reflect the short time course and heterogeneity of the bleomycin model.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
13 Valid · 0 Not valid · 8 Not checked · 94 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Through secretion of the senescence-associated secretory phenotype (SASP), a broad repertoire of cytokines, chemokines, matrix remodelling proteases and growth factors, senescent cells paracrinely promote proliferation and tissue deterioration8.”
§ Cellular senescence mediates fibrotic pulmonary disease > Abstract
What the sources say
- Partly supportedcites [8] van Deursen, J. M. The role of senescent cells in ageing. Nature 509, 439–446 (2014). sourceExperimental — accuracy not yet measured
In “Senescence is a multi-step evolving process” (page unavailable), the paper says SASP-mediated paracrine signalling affects cell proliferation. In “Senescence in ageing and age-related disease” (page unavailable), it says SASP components are thought to promote proliferation of neoplastic cells and may intensify age-related tissue deterioration. The citing sentence presents those qualified effects as established and general. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Cellular senescence is an evolutionarily conserved state of stable replicative arrest induced by pro-ageing stressors also implicated in IPF pathogenesis, including telomere attrition, oxidative stress, DNA damage and proteome instability.”
§ Cellular senescence mediates fibrotic pulmonary disease > Abstract
What the sources say
- Partly supportedcites [8] van Deursen, J. M. The role of senescent cells in ageing. Nature 509, 439–446 (2014). sourceExperimental — accuracy not yet measured
The Abstract and 'Senescence is a multi-step evolving process' describe growth arrest, including a transition to stable cell-cycle arrest. 'Causes and effector pathways of senescence' identifies telomere erosion, DNA lesions, reactive oxygen species and proteotoxic stress as senescence-related stressors. The cited passages do not establish that senescence is evolutionarily conserved or that these stressors are implicated in IPF pathogenesis; the paper also distinguishes replicative senescence from other forms of senescence. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Critically, impaired capacity to resolve fibrotic bleomycin injury has been associated with accumulation of apoptosis-resistant, senescent myofibroblasts3.”
§ Cellular senescence mediates fibrotic pulmonary disease > Results > Senescent cell retention impairs fibrosis resolution Taken together, our in vivo results strongly support the hypothesis that elimination of senescent cells improves fibrotic pulmonary disease when treatment is initiated at the onset of pathogenesis. We next sought to test the clinically important question of whether senescent cell clearance provides comparable benefit when initiated at a timepoint when pathology has fully developed. Ink-Attac mice contained a strong senescent signature in lung fibroblasts and epithelial cells 2 weeks post-bleomycin challenge (Fig. 2), a timepoint of well-established fibrotic remodelling in the lung15. Accordingly, we administered a single dose of bleomycin or PBS through aerosolized intratracheal administration to Ink-Attac mice. Two weeks post challenge, we randomized bleomycin-exposed mice to AP, DQ or vehicle treatment groups based on change in body weight and non-invasively measured airway resistance (Penh). Mice were treated for 2 weeks and were killed 4 weeks following bleomycin or PBS exposure (Fig. 5a). Body weight monitoring revealed that, similar to our previous experiments (Fig. 4f), mice that received bleomycin lost substantial body mass, relative to mice that received PBS. Upon treatment initiation on day 14, mean body weight of mice treated with AP plateaued, while vehicle-treated, bleomycin-exposed counterparts continued to lose weight (Fig. 5a), suggestive of physical benefit afforded by senescent cell clearance, even when treatment is initiated in later-stage disease. Spontaneous resolution is an inherent limitation of the bleomycin IPF model, with the rate and variability of bleomycin-induced pathology resolution dependent on complex factors, including genetic background and the microbiome3839. Indeed, both endpoint compliance (Supplementary Fig. 6) and comparison of Penh airway resistance at endpoint (4 weeks post challenge) to measures taken at the treatment randomization timepoint (2 weeks post challenge) revealed appreciable, albeit variable, improvement in all bleomycin-exposed groups, including vehicle-treated mice, with AP-treated mice showing greatest improvement (Fig. 5b). Thus, in our hands, the 3–4-week-period following a single bleomycin exposure represents a pivotal window of natural resolution (Figs 4 and 5a,b). Critically, impaired capacity to resolve fibrotic bleomycin injury has been associated with accumulation of apoptosis-resistant, senescent myofibroblasts3. As we were unable to disentangle senescence-dependent and -independent events governing resolution, we queried whether p16 expression, a measure of senescent burden, was associated with indicators of disease persistence. Impaired lung function, as measured by endpoint airway resistance (Penh) (Fig. 5c) and airway compliance (Fig. 5d), correlated significantly with p16 transcript abundance. This finding is consistent with associations drawn in humans, in which increased p16 expression correlated significantly with reduced FVC, pulmonary diffusion capacity and physical function (Supplementary Fig. 1). Similarly, in bleomycin-exposed mice, expression of the inflammatory and fibrogenic SASP factors Mcp1 (Fig. 5e), Pai1 (Fig. 5f), Mmp10 (Fig. 5g) and Col1a1 (Fig. 5h) robustly correlated with p16 transcriptional activation. These results further support the notion that the presence and activities of senescent cells may dictate resolution capacity following bleomycin-induced pathology.
What the sources say
- Supportedcites [3] Hecker, L. et al. Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance. Sci. Transl. Med. 6, 231ra247 (2014). source
The Introduction states that aged mice have impaired fibrosis resolution associated with senescent, apoptosis-resistant myofibroblasts. The Results identify bleomycin as the lung-injury model and report accumulation of senescent myofibroblasts in aged mice with persistent fibrosis. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Senescence was confirmed by expression profiling (p16, SASP factors) and/or SA-β-gal staining32 21 days post radiation.”
§ Cellular senescence mediates fibrotic pulmonary disease > Methods > Cell culture For experiments employing radiation-induced senescence, IMR90 (passages 5–7; ATCC, catalogue number CCL-186) and primary human fibroblasts (passages 3–6) were exposed to 10 Gy radiation or sham conditions using a RS2000 X-Ray Irradiator (RAD Source Technologies, Suwanee, GA). Normal bronchial epithelial cells (passages 4–7, Lot 7F3000, Lonza, Walkersville, MD) were exposed to 5 Gy or sham conditions. Senescence was confirmed by expression profiling (p16, SASP factors) and/or SA-β-gal staining32 21 days post radiation. For SA-β-gal staining, cells were fixed for 10 min in 2% formaldehyde+0.2% glutaraldehyde in PBS at room temperature. Cells were rinsed with PBS and incubated overnight in SA-β-gal staining solution containing the following: 1 mg ml−1 X-gal, 40 mM citric acid/sodium phosphate buffer pH 6.0, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 150 mM sodium chloride and 2 mM magnesium chloride in water. Cells were then rinsed in PBS and stored at 4 °C until imaging. Media applied 20 days post irradiation (or sham) was collected 24 h later and was diluted with NCM to reflect equivalent source cell concentrations. ProcartaPlex immunoassays (Affymetrix eBioscience) were used for CM secretome composition assessment, according to the manufacturer's specifications. Non-irradiated IMR90 cells (passages 5–7) were treated with NCM, NCM+2 ng ml−1 TGFβ, CCM or SASP-CM and applied to downstream analyses as indicated. Primary human fibroblasts collected from human patients were authenticated through αSMA staining. For senolytic treatment, sham and irradiated primary human fibroblasts were treated with indicated concentrations of DQ or navitoclax for 3 days, starting at day 20 post irradiation or sham exposure. Cell viability after drug treatment was measured by ATPLite Kits (PerkinElmer; Waltham, MA) performed according the manufacturer's instructions. Luminescence was read using a multi-scan plate reader (Fisher). For experiments utilizing etoposide-induced senescence, IMR90 human lung fibroblasts (passage 10; ATCC) were treated for 48 h with 20 μM etoposide (Enzo Life Sciences, Farmingdale, NY). Etoposide was removed and replaced with fresh media. Six days after etoposide removal, approximately 60% of IMR90 cells were SA-β-gal positive. Cells were treated for 48 h with 20 μM D+15 μM Q or 10 μM navitoclax (or untreated control) and the percentage of SA-β-gal-positive cells was determined using a C12FDG-based senescence assay described as follows46. Briefly, etoposide-treated senescent IMR90 cells were seeded at a concentration of 5 × 103 cells per well in 96-well plates 24 h before treatment. Following addition of the drugs, the cells were incubated for 48 h under 20% O2 oxygen conditions. For fluorescence analysis of SA-β-gal activity, cells were incubated for 1 h with 100 nM Bafilomycin A1 (Calbiochem, San Diego, CA). Next, 10 μM C12FDG (Setareh Biotech, Eugene, OR) was added to the culture medium and the cells were incubated for 1.5–2 h. Ten minutes before analysis, the DNA intercalating Hoechst dye (2 μg ml−1) was added to the cells. For quantitative analysis of cell number (Hoechst staining) and number of C12FDG-positive senescent cells, a laser-based line scanning confocal imager IN Cell 6000 Analyzer was used. All samples were analysed in duplicate with three to five fields per well.
What the sources say
- Partly supportedcites [32] Baker, D. J. et al. Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 530, 184–189 (2016). sourceExperimental — accuracy not yet measured
In “ATTAC clears senescent adipocyte progenitor cells” (page unavailable), the paper identifies cells using p16 expression, other senescence markers, and SAβ-Gal staining. It studies naturally occurring senescent cells, however, and does not support the claim’s 21-day post-radiation condition. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Importantly, CM collected from irradiated bronchiolar epithelial cells did not activate a fibrogenic response, as measured by αSMA fibrotic activation of naive IMR90 cells (Supplementary Fig. 2), suggesting that cell-type-specific SASP composition may differentially affect pathological phenotypes within the lung.”
§ Cellular senescence mediates fibrotic pulmonary disease > Results > The secretome of senescent fibroblasts is profibrotic
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
61 more claims
Create a free account to see all 115 claims and to verify the 5 references still open.
- It may state two separate claims as one. 29
- Probably not a substantial claim. 26
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is in agreement with a recent report showing that the removal of senescent cells expressing high levels of p16INK4a can lead to fibrosis in mice101, whereas small-molecule senolytics appear to reduce fibrosis in several mouse tissues22,71,73,75,102.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [71]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“in a mouse model of idiopathic pulmonary fibrosis (IPF), D + Q treatment improved lung compliance and reduced frailty71.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [71]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Patients with IPF accumulate TAFs and senescence markers in lungs that increase with disease severity and activate SASP52.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The use of various natural flavonoids, including quercetin and fisetin, either alone or in combination with dasatinib, a pan-tyrosine kinase inhibitor, can stimulate senolysis in a variety of contexts in vitro and in vivo199,207–210.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [199]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“consistent with enhanced paracrine signaling from increased numbers of senescent neighbors and with established features of epithelial aging.23,25,32–35”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [33]
Experimental — accuracy not yet measured
35 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Self-citationNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876 · cited 2×
“Attenuation of age-related pathologies and extension of lifespan in chronologically aged mice has been demonstrated using the same transgenic strategy 32–34 , and improvements in lung structure and function in aged mice have recently been demonstrated using a similar suicide-gene strategy 20 .”
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584 · cited 2×
“An alternative approach to transgenic senescent cell clearance is senolytics 21,22 , which may be a tractable treatment option for humans.”
Self-citationDesmoulière, A., Geinoz, A., Gabbiani, F., & Gabbiani, G. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.103 · Cited by 2,243
King, T. E., Pardo, A., & Selman, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60052-4 · Cited by 2,194
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Cited by
Items 701–800 of 1,619
Aging, Plasminogen Activator Inhibitor 1, Brain Cell Senescence, and Alzheimer's Disease.
Jiang, C., Rana, T., Jin, L., Farr, S. A., Morley, J. E., Qin, H., Liu, G., & Liu, R.-M. (2023) · PubMed Central · doi:10.14336/ad.2022.1220 · Cited by 23
“It has been well documented that the number of senescent cells increases with age and in aging-related diseases, including AD [1, 3-8, 38-40].”
BackgroundJia, M., Rosas, L., Kapetanaki, M. G., Tabib, T., Sebrat, J., Cruz, T., Bondonese, A., Mora, A. L., Lafyatis, R., Rojas, M. M., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02419-0 · Cited by 27
“Thus, early targeting of senescent fibroblasts with senolytic cocktails may help manage or even reverse the disease [51, 52].”
BackgroundBientinesi, E., Ristori, S., Lulli, M., & Monti, D. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111957 · Cited by 26
Induction, regulation and roles of neural adhesion molecule L1CAM in cellular senescence
Mrázková, B., Dzijak, R., Hornofova, T., Kyjacová, L., Baráth, P., Džubák, P., Holub, D., Hajdúch, M., Nahácka, Z., Anděra, L., et al. (2018) · Aging · doi:10.18632/aging.101404 · Cited by 29
“These effects are thought to be elicited by secretion from SC of a complex mixture of factors comprising components of the extracellular matrix, its modifiers such as proteases and their regulators, reactive oxygen species [11] and particularly cytokines including morphogens from the TGFβ family, pro-inflammatory spec…”
Senescent cells: A new Achilles’ heel to exploit for cancer medicine?
Zhang, B., Lam, E. W. ‐., & Sun, Y. (2018) · Aging Cell · doi:10.1111/acel.12875 · Cited by 24
Chung, E. J., Reedy, J. L., Kwon, S., Patil, S. S., Valle, L., White, A. O., & Citrin, D. E. (2019) · Radiation Research · doi:10.1667/rr15356.1 · Cited by 24
“Furthermore, it has been demonstrated that fibrosis-inducing doses of radiation increase AECII senescence, and these senescent AECIIs stimulate fibroblast proliferation and collagen secretion (9, 10).”
BackgroundBone Marrow-Derived Progenitor Cells Contribute to Remodeling of the Postpartum Uterus
Tal, R., Kisa, J., Abuwala, N., Kliman, H. J., Shaikh, S., Chen, A. Y., Lyu, F., & Taylor, H. S. (2021) · Stem Cells · doi:10.1002/stem.3431 · Cited by 23
“may be essential for scarless uterus healing since abnormal accumulation and lack of clearance of senescent cells has been previously linked to various pathologies of tissue fibrosis as well as preterm birth.(53,54) Interestingly, we found that while initially in the immediate”
BackgroundObesity, Senescence, and Senolytics
Chaib, S., Tchkonia, T., & Kirkland, J. L. (2021) · Handbook of Experimental Pharmacology · doi:10.1007/164_2021_555 · Cited by 22
Self-citationCellular senescence and frailty: a comprehensive insight into the causal links
Marcozzi, S., Bigossi, G., Giuliani, M. E., Giacconi, R., Piacenza, F., Cardelli, M., Brunetti, D., Segala, A., Valerio, A., Nisoli, E., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00960-w · Cited by 28
Dasatinib and Quercetin Limit Gingival Senescence, Inflammation, and Bone Loss
Rattanaprukskul, K., Xia, X.-J., Hysa, M., Jiang, M., Hung, M., Suslavich, S. F., & Sahingur, S. E. (2025) · Journal of Dental Research · doi:10.1177/00220345241299789 · Cited by 26
“…within the gingival tissue of aged mice treated with DQ compared with vehicle-treated controls, aligning with the impact of DQ in other conditions such as metabolic dysfunction, intervertebral disc degeneration, and lung disease (Schafer et al. 2017; Novais et al. 2021; Islam et al. 2023).”
Eskiocak, O., Gewolb, J., Shah, V., Rouse, J. A., Chowdhury, S., Akyildiz, E. O., Fernández-Maestre, I., Boyer, J. A., Filliol, A. A., Harris, A. S., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-01022-w · Cited by 35
PAI-1: A New Target for Controlling Lung-Cell Senescence and Fibrosis?
Adnot, S., Breau, M., & Houssaini, A. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0341ed · Cited by 25
“Genetic elimination of senescent cells in the bleomycin model attenuates lung fibrosis (12) similarly to PAI-1 inactivation (13, 14).”
BackgroundRostami, M. R., & Bradić, M. (2021) · Mobile DNA · doi:10.1186/s13100-021-00241-3 · Cited by 22
Dynamic Aging: Channeled Through Microenvironment
Tan, Q., Liang, N., Zhang, X., & Li, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.702276 · Cited by 28
Li, S., Gao, S., Jiang, Q., Liang, Q. L., Luan, J., Zhang, R., Zhang, F., Ruan, H., Li, X., Li, X., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108271 · Cited by 23
Role of low-dose radiation in senescence and aging: A beneficial perspective
Xu, J., Liu, D., Zhao, D., Jiang, X. M., Meng, X., Jiang, L., Meina, Y., Zhang, L., & Jiang, H. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120644 · Cited by 32
Takaya, K., Asou, T., & Kishi, K. (2022) · GeroScience · doi:10.1007/s11357-022-00648-7 · Cited by 24
“Other senescent cell-depleting agents, such as dasatinib and quercetin [24], induce apoptosis in a subset of senescent cells.”
BackgroundTu, M., Wei, T., Jia, Y., Wang, Y., & Wu, J. (2022) · Journal of Thoracic Disease · doi:10.21037/jtd-22-886 · Cited by 29
“Both lung fibroblasts and alveolar epithelial cells show evidence of SASPs acquired from the lungs of patients with IPF (108,117).”
Rodríguez-Agustín, A., Casanova, V., Grau-Expósito, J., Sánchez‐Palomino, S., Alcamí, J., & Climent, N. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030917 · Cited by 28
“Since this first observation, D or D+Q senolytic strategies have been successfully used in a wide range of mouse models of diseases such as lung fibrosis [150], renal fibrosis [151], T2 diabetes [152] vascular pathology and atherosclerosis [153].”
BackgroundKulkarni, T., Kurundkar, A., Kim, Y.-I., de Andrade, J. A., Luckhardt, T., & Thannickal, V. J. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2019.105821 · Cited by 21
Organismal Aging and Oxidants beyond Macromolecules Damage
Clement, M., & Luo, L. (2019) · PROTEOMICS · doi:10.1002/pmic.201800400 · Cited by 23
Bonifazi, M., Vincenzo, M. D., Caffarini, M., Mei, F., Salati, M., Zuccatosta, L., Refai, M., Mattioli‐Belmonte, M., Gasparini, S., & Orciani, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218140 · Cited by 22
End-Stage Idiopathic Pulmonary Fibrosis Lung Microenvironment Promotes Impaired NK Activity
Cruz, T., Garcia, P. A. A., Chamucero-Millares, J. A., Bondonese, A., Mitash, N., Sembrat, J., Tabib, T., Zhang, W., Seyed, N., Peters, V., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300182 · Cited by 29
Tu, M., Lu, C., Jia, H., Chen, S., Wang, Y., Li, J., Cheng, J., Yang, M., & Zhang, G. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05698-3 · Cited by 20
Senescent cell depletion alleviates obesity-related metabolic and cardiac disorders
Silva, T. D. O., Lunardon, G., Lino, C. A., Silva, A. D. A., Zhang, S., Irigoyen, M. C., Lu, Y. W., Mably, J. D., Barreto‐Chaves, M. L. M., Wang, D., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102065 · Cited by 28
Immunosenescence in autoimmune diseases
Hu, H., Zhang, G., Chen, T., Liu, Y., Meng, L., Holmdahl, R., Dai, L., & Zhao, Y. C. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103805 · Cited by 31
Endothelial senescent-cell-specific clearance alleviates metabolic dysfunction in obese mice
Suda, M., Chaib, S., Prata, L. G. P. L., Zhu, Y. Z., Tripathi, U., Paul, K. H., Palmer, A. K., Pirtskhalava, T., Kulshreshtha, V., Inman, C. L., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.10.009 · Cited by 27
Self-citationGuo, G., Watterson, S., Zhang, S., Bjourson, A. J., McGilligan, V., Peace, A. J., & Singh, T. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101363 · Cited by 25
“, 2016), idiopathic pulmonary fibrosis (Schafer et al., 2017),”
Intersection of Inflammation and Senescence in the Aging Lung Stem Cell Niche
Allen, N. C., Reyes, N. S., Lee, J. Y., & Peng, T. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.932723 · Cited by 25
Chen, H., Lv, L., Liang, R., Guo, W., Liao, Z., Chen, Y., Zhu, K., Huang, R., Zhao, H., Qin, P., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17539 · Cited by 21
Li, H., Cui, H., Ren, J. L., Wang, D., Zhao, R., Zhu, S., Liu, S., Liu, X., Tian, S., Zhang, Y., et al. (2023) · Cell Transplantation · doi:10.1177/09636897231162526 · Cited by 24
Antisenescence Therapy Improves Function in a Human Model of Cardiac Fibrosis-on-a-Chip
Mourad, O., Mastikhina, O., Khan, S. T., Sun, X., Hatkar, R., Williams, K., & Nunes, S. S. (2023) · ACS Materials Au · doi:10.1021/acsmaterialsau.3c00009 · Cited by 26
Quercetin in Idiopathic Pulmonary Fibrosis: Another Brick in the Senolytic Wall
Sellarés, J., & Rojas, M. M. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0267ed · Cited by 22
Habiel, D. M., Hohmann, M. S., Espíndola, M. S., Coelho, A. L., Jones, I. C., Jones, H. D., Carnibella, R. P., Pinar, I. P., Werdiger, F., & Hogaboam, C. M. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0922-7 · Cited by 22
Senescence and fibrosis in salivary gland aging and disease
Nelson, D. A., Kazanjian, I., Melendez, J. A., & Larsen, M. (2024) · Journal of Oral Biology and Craniofacial Research · doi:10.1016/j.jobcr.2024.02.009 · Cited by 29
“55,61,74,75 For example, treatment with the senolytic drugs, dasatinib and quercetin, improved lung function in idiopathic pulmonary fibrosis (IPF) lung models in mice 55 and has had promising results in treating human disease.”
BackgroundSenescent endothelial cells promote pathogenic neutrophil trafficking in inflamed tissues
Rolas, L., Stein, M., Barkaway, A., Reglero-Real, N., Sciacca, E., Yaseen, M., Wang, H., Vázquez-Martínez, L., Golding, M., Blacksell, I. A., et al. (2024) · EMBO Reports · doi:10.1038/s44319-024-00182-x · Cited by 26
“…accumulation of senescent cells in various chronic in fl ammatory conditions such as in lungs in idiopathic pulmonary fi brosis (Justice et al, 2019; Schafer et al, 2017), in the aorta in atherosclerosis (Minamino et al, 2002; Roos et al, 2016), and in adipose tissue of patients with diabetes…”
BackgroundAdvances in idiopathic pulmonary fibrosis diagnosis and treatment
Liu, H., Shen, J., & He, C. (2025) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2025.02.001 · Cited by 23
Mechanical Signaling: Molecular Mechanisms, Biological Functions, Diseases, and Therapeutic Targets
Long, Y., Wang, P., Lei, J., Su, B., Wei, Q., & Liu, X. (2025) · MedComm · doi:10.1002/mco2.70523 · Cited by 32
“Also, polyacrylamine-based TFM has been employed to quantify the aging-dependence of cellular contractility in endothelial cells [175], fibroblasts [176], and VSMCs [177].”
Is the association between diabetes mellitus and pulmonary fibrosis real?
Kumar, V., & Nawroth, P. P. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00577-z · Cited by 20
Wang, X., Honda, Y., Zhao, J., Morikuni, H., Nishiura, A., Hashimoto, Y., & Matsumoto, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212415 · Cited by 23
“D and Q alone, or a combination of the two, are the most-studied senolytic drugs [28]—where D is an antineoplastic agent used in the treatment of acute lymphocytic leukemia, chronic granulocytic leukemia, and leukemic leukemia [29]; Q is a flavonoid with antioxidant, anti-inflammatory, immunoprotective properties, or…”
BackgroundNew Trends in Aging Drug Discovery
Benhamú, B., Martín‐Fontecha, M., Vázquez‐Villa, H., López-Rodríguez, M. L., & Ortega‐Gutiérrez, S. (2022) · Biomedicines · doi:10.3390/biomedicines10082006 · Cited by 22
“Most importantly, a first-in-human study further showed that senotherapy with D + Q significantly improved pulmonary function during exercise in IPF patients after three weeks of intermittent treatment (NCT02874989, Table 1).”
BackgroundInfluentialSalas-Venegas, V., Santín-Márquez, R., Carreto, R. J. R., Rodríguez-Cortés, Y. M., Cano-Martínez, A., Luna‐López, A., Chavarría, A., Königsberg, M., & López‐Díazguerrero, N. E. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1162747 · Cited by 22
“It is known that senescent cells accumulate during obesity (Minamino et al., 2009; Ogrodnik et al., 2017; Schafer et al., 2017).”
BackgroundMeiners, F., Hinz, B., Boeckmann, L., Secci, R., Sueto, S. O. B., Kuepfer, L., Fuellen, G., & Barrantes, I. (2024) · Scientific Reports · doi:10.1038/s41598-024-55870-4 · Cited by 22
NR2F2 alleviates pulmonary fibrosis by inhibition of epithelial cell senescence
Wan, R., Long, S., Ma, S., Yan, P., Li, Z., Xu, K., Lian, H., Li, W., Duan, Y., Zhu, M., et al. (2024) · Respiratory Research · doi:10.1186/s12931-024-02777-3 · Cited by 26
“Previous studies have shown the presence of cellular senescence markers, such as increased expression of p16, p21, and elevated senescence-associated β-galactosidase activity, in fibroblasts and epithelial cells of lung tissues from IPF patients [12–14].”
BackgroundInfluentialShao, M., Qiu, Y., Shen, M., Liu, W. Q., Feng, D., Luo, Z., & Zhou, Y. (2024) · The FASEB Journal · doi:10.1096/fj.202302547rr · Cited by 27
“21 Therefore, promoting apoptosis of senescent myo-fibroblasts and targeting their elimination have become new strategies for the treatment of pulmonary fibrosis in recent years.”
Immunosenescence: A new direction in anti-aging research
Li, H., Lin, S., Wang, Y., Shi, Y., Fang, X., Wang, J., Cui, H., Bian, Y., & Qi, X. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112900 · Cited by 23
Obesity-induced neuronal senescence: Unraveling the pathophysiological links
Ghosh, P., Fontanella, R. A., Scisciola, L., Taktaz, F., Pesapane, A., Basilicata, M. G., Tortorella, G., Matacchione, G., Capuano, A., Vietri, M. T., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102533 · Cited by 25
Biomarkers of cellular senescence and major health outcomes in older adults
Cummings, S. R., Lui, L., Aversa, Z., Mau, T., Fielding, R. A., Atkinson, E. J., Patel, S., & LeBrasseur, N. K. (2024) · GeroScience · doi:10.1007/s11357-024-01474-9 · Cited by 28
Self-citationSenolytic drugs in respiratory medicine: is it an appropriate therapeutic approach?
Cazzola, M., Matera, M. G., Rogliani, P., & Calzetta, L. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1492548 · Cited by 20
“tion killed irradiation-induced senescent primary human fibroblasts more efficiently than navitoclax in vitro [29].”
BackgroundInfluentialCauses of Pulmonary Fibrosis in the Elderly
Ramírez, C. L., Suárez-Valdivia, L., & Portal, J. A. R. (2018) · Medical Sciences · doi:10.3390/medsci6030058 · Cited by 32
“Treatment of mice with drugs that induce apoptosis specifically in senescent cells, termed senolytics, mirrored the results observed with transgenic cell clearance [60].”
ResultZeng, X., Gao, D.-D., & Zhang, F. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156004 · Cited by 22
Hugo, C., Asante, I., Sadybekov, A., Katritch, V., & Yassine, H. N. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2024.0794 · Cited by 19
“Senescence-associated LT release drives the pro fi brotic features of chronic in fl ammation (Schafer et al., 2017; Wiley et al., 2019).”
Yang, G., Dong, C., Wu, Z., Wu, P., Cao, Y., Li, L., Zhang, J., & Wu, X. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.02.036 · Cited by 37
“These results collectively suggest that fibrotic polarization of NPCs plays an important role in NP tissue degeneration, in line with previous findings [1,31].”
Yadav, S., Anbalagan, M., Khatun, S., Prabhakaran, D., Matsunaga, Y., Manges, J., McLachlan, J. B., Lasky, J. A., Kolls, J. K., & Thannickal, V. J. (2025) · Journal of Clinical Investigation · doi:10.1172/jci181775 · Cited by 26
“…including organ fibrosis (21, 22). p16 Ink4a -expressing cells, both epithelial and mesenchymal, have been found to be increased in lung samples of individuals with IPF (4, 5, 23), and senolytic clearance by pharmacologic approaches have been proposed as a potential treatment for IPF (24).”
InfluentialCD4 T cells acquire Eomesodermin to modulate cellular senescence and aging
Elyahu, Y., Feygin, I., Eremenko, E., Pinkas, N., Zemer, A., Shicht, A., Berner, O., Avigdory-Meiri, R., Nemirovsky, A., Reshef, K., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00953-8 · Cited by 21
“Cellular senescence has been implicated in the pathogenesis of several chronic immune-mediated diseases, including rheumatoid arthritis 39 , pulmonary fibrosis 40 and liver cirrhosis 41,42 .”
Boesch, M., Baty, F., Brutsche, M. H., Tamm, M., Roux, J., Knudsen, L., Gazdhar, A., Geiser, T., Khan, P., & Hostettler, K. (2020) · Respiratory Research · doi:10.1186/s12931-020-01414-z · Cited by 20
Cellular senescence in vivo: From cells to tissues to pathologies
Kumar, A., Bano, D., & Ehninger, D. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111308 · Cited by 20
BAL Transcriptomes Characterize Idiopathic Pulmonary Fibrosis Endotypes With Prognostic Impact
Sadeleer, L. D., Verleden, S. E., Schupp, J. C., McDonough, J. E., Goos, T., Yserbyt, J., Bargagli, E., Rottoli, P., Kaminski, N., Prasse, A., et al. (2022) · CHEST Journal · doi:10.1016/j.chest.2021.12.668 · Cited by 27
Xiong, J., Duan, J., Jiang, N., Zhang, C., Zhong, W., Yang, J., Liu, Y., Su, F., Zhou, Y., Li, D., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109339 · Cited by 20
Sorokina, A. G., Orlova, Y. A., Grigorieva, O., Novoseletskaya, E. S., Basalova, N. A., Alexandrushkina, N. A., Vigovskiy, M. A., Kirillova, K. I., Balatsky, A. V., Samokhodskaya, L. M., et al. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112176 · Cited by 25
Potential biomarkers for diagnosis and disease evaluation of idiopathic pulmonary fibrosis
Wang, Q., Xie, Z., Wan, N., Yang, L., Jin, Z., Jin, F., Huang, Z., Chen, M., Wang, H., & Feng, J. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002171 · Cited by 23
“Among the biomarkers differentially expressed in the IPF group, the following biomarkers are related to the severity of the disease: KL-6, RAGE,([17]) M2BP,([33]) SAA,([28]) CEA,([39]) MMP3,([45]) MMP7,([9,42,50,54]) MMP10,([50]) MMP28,([61]) YKL-40,([79]) a-defensin,([97]) CXCL8,([170]) CXCL13,([45]) CCL2,([115]) ICA…”
BackgroundSavić, R., Yang, J., Koplev, S., An, M. C., Patel, P. L., O’Brien, R., Dubose, B. N., Dodatko, T., Rogatsky, E., Sukhavasi, K., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113371 · Cited by 23
“41 While COL6A3 has been previously found as differentially expressed (high-throughput omics assays) in senescent cells, 42 to the best of our knowledge, this paper presents extensive characterization of COL6A3 as a driver of senescence-associated molecular programs.”
BackgroundWang, X., Xu, Y., Zhang, S., Zhu, X., Zhang, H., & Liu, Y. (2023) · Acta Physiologica · doi:10.1111/apha.14059 · Cited by 19
“3,4,6 Among somatic cells of the lung, alveolar type II (AT2) cells as the progenitors of the alveolar epithelium are the most likely to transition to the senescent phenotype during the development of aging-related lung disease including pulmonary fibrosis.”
BackgroundQamsari, E. S., & Stewart, D. J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1403669 · Cited by 24
Sharma, R., & Padwad, Y. S. (2019) · Nutrition · doi:10.1016/j.nut.2019.01.020 · Cited by 21
Aging Biomarkers and Novel Targets for Anti-Aging Interventions
Xu, K., Guo, Y., Li, Z., & Wang, Z. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-25650-0_3 · Cited by 26
P16INK4a played a critical role in exacerbating acute tubular necrosis in acute kidney injury.
Gu, X., Peng, C., Lin, S., Qin, Z., Liang, J., Chen, H., Hou, C.-X., Wang, R., Du, Y., Jin, J., et al. (2019) · PubMed · Cited by 26
Song, S., Perez, J. V., Svitko, W., Ricketts, M. D., Dean, E., Schultz, D., Marmorstein, R., & Johnson, F. B. (2019) · Aging Cell · doi:10.1111/acel.13061 · Cited by 20
“…stem cell depletion (Krishnamurthy et al., 2006; Molofsky et al., 2006) or by disruption of tissue structure and function, apparently via secretion of factors such as proteases and inflammatory cytokines (Baar et al., 2017; Baker et al., 2016, 2011; Childs et al., 2016; Schafer et al., 2017).”
BackgroundSenotherapeutics for HIV and aging
Szaniawski, M. A., & Spivak, A. M. (2019) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000609 · Cited by 25
Senescence of alveolar stem cells drives progressive pulmonary fibrosisPreprint
Yao, C., Guan, X., Carraro, G., Parimon, T., Liu, X., Huang, G.-L., Soukiasian, H., David, G., Weigt, S., Belperio, J., et al. (2019) · bioRxiv · doi:10.1101/820175 · Cited by 21
“Recent studies have implicated mechanisms of accelerated aging, including loss of epithelial progenitor cell function and/or numbers and cellular senescence, in IPF pathogenesis (10-13).”
BackgroundSalminen, A. (2024) · Biogerontology · doi:10.1007/s10522-024-10114-w · Cited by 29
“For example, there is clear evidence that cellular senescence, especially the senescence of stromal fibroblasts, enhanced the pathogenesis of fibrotic diseases, e.g., the clearance of senescent fibroblasts reduced the severity of fibrotic pulmonary lesions in mice (Schafer et al. 2017).”
BackgroundZhang, T., Hou, Z., Ding, Z., Wang, P., Pan, X., & Li, X. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70402 · Cited by 19
Licence to kill senescent cells in idiopathic pulmonary fibrosis?
Mailleux, A., & Crestani, B. (2017) · European Respiratory Journal · doi:10.1183/13993003.01360-2017 · Cited by 21
Insights into the Pathogenesis of Pulmonary Fibrosis from Genetic Diseases
Wang, J. Y., & Young, L. R. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0557tr · Cited by 20
Huang, C., Xue, X., Gong, N., & Jiang, J. (2022) · Environmental Toxicology · doi:10.1002/tox.23597 · Cited by 21
“Elimination of senescent cells by suicide gene or senolytic strategies could suppress bleomycin-induced decline of lung function and physical health.(38) Rg1, as the major active component in ginseng, exhibits antiaging, rejuvenating, immune-potentiating and antioxidant activities.”
BackgroundNovel mediators of idiopathic pulmonary fibrosis
Saito, S., Deskin, B., Rehan, M., Yadav, S., Matsunaga, Y., Lasky, J. A., & Thannickal, V. J. (2022) · Clinical Science · doi:10.1042/cs20210878 · Cited by 20
The ageing immune system as a potential target of senolytics
Du, P. Y., Gandhi, A., Bawa, M., & Gromala, J. (2023) · Oxford Open Immunology · doi:10.1093/oxfimm/iqad004 · Cited by 22
“Promising results have already been reported with use of dasatinib & quercetin (DþQ) in diabetic kidney disease [30] and IPF [31, 32]; both trialled in humans and mice.”
BackgroundInfluentialSun, W., Yang, X., Duan, C., Jing, X., Gao, L., Huang, H., Guo, L., Yang, Y., & Xu, Z. (2023) · Cell Biology International · doi:10.1002/cbin.12062 · Cited by 20
Phytochemicals and Vitamin D for a Healthy Life and Prevention of Diseases
Santa, K., Watanabe, K., Kumazawa, Y., & Nagaoka, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512167 · Cited by 21
“Some intriguing research has shown that flavonoids suppress lung fibrosis [123].”
BackgroundLiu, Z., Zhang, Y., Li, D., & Fu, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116463 · Cited by 20
A single-cell atlas of lung homeostasis reveals dynamic changes during development and aging
Jia, H., Chang, Y., Chen, Y., Chen, X., Zhang, H., Hua, X., Xu, M., Sheng, Y., Zhang, N., Cui, H., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06111-x · Cited by 22
“FB is involved in the morphogenesis of the lung during development 34 , and during aging, lung compliance decreases, in which FB is involved in the process of interstitial remodeling 35 .”
FRMD6 determines the cell fate towards senescence: involvement of the Hippo-YAP-CCN3 axis
Park, J.-J., Lee, S. J., Baek, M., Lee, O.-J., Nam, S., Kim, J., Kim, E., Shin, E., & Kim, E. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01333-2 · Cited by 23
“Although they seem to in fl uence distinct YAP functions, they likely cooperate to suppress tumor development.”
Hernández‐González, F., Pietrocola, F., Cameli, P., Bargagli, E., Prieto‐González, S., Cruz, T., Mendoza, N., Rojas, M. M., Serrano, M., Agustí, A. G. N., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147554 · Cited by 19
“In this regard, studies have shown that senescent cells alone can induce lung tissue dysfunction associated with aging, reinforcing the suggested causal link between senescent cell accumulation, aging, and disease [12,13].”
BackgroundAutophagy in Tissue Repair and Regeneration
Moreno-Blas, D., Adell, T., & González‐Estévez, C. (2025) · Cells · doi:10.3390/cells14040282 · Cited by 26
Sadeleer, L. D., Goos, T., Yserbyt, J., & Wuyts, W. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061722 · Cited by 20
“While these pathways do not reach the full attention of the ILD clinician, as no targeting treatment is available, trials are underway to investigate the potential impact on the progression of fibrosis: thyroid hormone has been suggested for mitigating mitochondrial dysfunction [56], Dasatinib‐Quercitin, which inhibit…”
BackgroundPenumatsa, K. C., Falcão‐Pires, I., Leite, S., Leite-Moreira, A. F., Bhedi, C. D., Nasirova, S., Ma, J., Sutliff, R. L., & Fanburg, B. L. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.560019 · Cited by 18
“Agingassociated fibrosis also occurs in other organs, including lungs (Schafer et al., 2017; Sicard et al., 2018); the prevalence of chronic lung diseases and idiopathic pulmonary fibrosis in the elderly may reflect this occurrence (Budinger et al.”
BackgroundThe potential role of senescence in limiting fibrosis caused by aging
Meng, X., Wang, H., Song, X., Clifton, A. C., & Xiao, J. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29313 · Cited by 19
“Early‐intervention suicide‐gene‐mediated senescent cell ablation by D+Q improved pulmonary function in a bleomycin‐injury idiopathic pulmonary fibrosis (IPF) mice model (Schafer et al., 2017).”
BackgroundSharma, R. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.3970 · Cited by 20
Brazee, P. L., Allen, N., Knipe, R. S., Redente, E. F., & Saux, C. J. L. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2649-9402 · Cited by 27
“32,117,118 Novel therapeutics,includingtherecentFDA-approvedBH3mimeticsthat target apoptotic resistant fi broblast, have shown ef fi cacy in reducing persistent fi brosis after repetitive-dose bleomycin.”
Small airway disease as a key factor in COPD: new perspectives and insights
Zhou, R., Wang, H., Zhang, Y., Mai, J., & Yang, L. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1648612 · Cited by 19
“…mouse model of pulmonary fibrosis (simulating IPF), the combination of dasatinib and quercetin (D + Q) reduced senescent fibroblasts and epithelial cells, decreased expression of fibrotic factors such as type I collagen α 1 chain (Col1a1) and TGF-β , and improved lung compliance (154).”
Sakai, T., Takagaki, H., Yamagiwa, N., Ui, M., Hatta, S., & Imai, J. (2021) · Antioxidants · doi:10.3390/antiox10091398 · Cited by 17
“Therefore, in BLM-induced pulmonary fibrosis model mice, senescent alveolar epithelial cells contribute to the development of pulmonary fibrosis; moreover, the removal of senescent alveolar epithelial cells by senolytic drugs suppresses the induction of fibrosis [54,55].”
BackgroundFleyshman, D. I., Wakshlag, J. J., Huson, H. J., Loftus, J. P., Olby, N. J., Brodsky, L., Gudkov, A. V., & Andrianova, E. L. (2021) · Aging · doi:10.18632/aging.203600 · Cited by 19
Yang, J., Wu, S., Hu, W., Yang, D., Ma, J., Cai, Q., Xue, J., Chen, J., Li, F., Zeng, J., et al. (2022) · Toxicology · doi:10.1016/j.tox.2022.153152 · Cited by 17
Transposon control as a checkpoint for tissue regeneration
Angileri, K. M., Bagia, N. A., & Feschotte, C. (2022) · Development · doi:10.1242/dev.191957 · Cited by 15
Senescence-associated exosomes transfer miRNA-induced fibrosis to neighboring cells
Lee, A. H., Ghosh, D., Koh, I. L., & Dawson, M. (2023) · Aging · doi:10.18632/aging.204539 · Cited by 28
Li, Y., An, X.-L., Jin, F., Bai, Y.-F., Li, T., Yang, X., Liu, S., Gao, X., Mao, N., Xu, H., et al. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115410 · Cited by 19
Tools to eliminate senescent cells
Serrano, M. (2017) · Nature · doi:10.1038/nature22493 · Cited by 19
Biobanking and cryopreservation of human lung explants for omic analysis
Chu, S. G., Poli, S., Sakairi, Y., Kelly, R. S., Chase, R., Konishi, K., Blau, A., Tsai, E. A., Tsoyi, K., Padera, R. F., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01635-2018 · Cited by 18
Xu, W., Zhao, T., Chen, H., Huang, N., Gong, H., Zhang, J., Yu, Y., Li, T., Zhang, G., Gong, C., et al. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115045 · Cited by 23
Arai, Y., Chavkin, N. W., Arai, Y., Halvardson, J., Bjurling, J., Doviak, H., Cochran, J. D., Evans, M. A., Horitani, K., Yura, Y., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adv4071 · Cited by 17
Metadata
- Authors
- Schafer, M. J., White, T. A., Iijima, K., Haak, A. J., Ligresti, G., Atkinson, E. J., Oberg, A. L., Birch, J., Salmonowicz, H., Zhu, Y., Mazula, D. L., Brooks, R. W., Fuhrmann-Stroissnigg, H., Pirtskhalava, T., Prakash, Y. S., Tchkonia, T., Robbins, P. D., Aubry, M. C., Passos, J. F., Kirkland, J. L., Tschumperlin, D. J., Kita, H., & LeBrasseur, N. K.
- Affiliations
- Mayo Clinic (US)
- Newcastle University (GB)
- Scripps Research Institute (US)
- Corresponding author
- LeBrasseur, Nathan K.
- ORCID
- Venue
- Nature Communications
- Published
- 2017-02-23
- Volume
- 8
- Issue
- 1
- Pages
- 14532-14532
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5331226
- OpenAlex
- W2591114726
- Cited by
- 1,613
- References
- 52
- Citations by year
- 2026: 195 · 2025: 205 · 2024: 193 · 2023: 193 · 2022: 192 · 2021: 181 · 2020: 176 · 2019: 128 · 2018: 107 · 2017: 42
- FWCI
- 91.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- Mayo Clinic (UL1-TR000135)
- Glenn Foundation for Medical Research
- Louisiana Transportation Research Center
- Georgia Clinical and Translational Science Alliance (UL1 TR000135)
- Noaber Foundation
- Fondation pour la Recherche Médicale
- National Institutes of Health (UL1TR000135, 2r01hl092961-13)
- Directorate for Biological Sciences
- Biotechnology and Biological Sciences Research Council (BB/K017314/1, BB/H022384/1)
- National Institute on Aging (R01AG053832, R01AG013925, R37AG013925)
- National Heart, Lung, and Blood Institute (R01-HL-092961)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- cellular senescence, idiopathic pulmonary fibrosis, senolytics, senescence-associated secretory phenotype, senescent fibroblasts, p16, bleomycin-induced lung injury, interstitial pulmonary fibrosis, suicide gene therapy, lung function
- MeSH terms
- Animals, Bleomycin, Fibroblasts, Humans, Lung, Male, Biomarkers, Cellular Senescence, Cyclin-Dependent Kinase Inhibitor p16, Proteome, Mice, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.